Background Extracorporeal membrane oxygenation (ECMO) has shown variable results in
COVID‐19 pneumonia however, some evidence supports benefit. Here we compare our …

Background Despite increasing knowledge about the optimal treatment for patients with
severe COVID‐19, data from different cohorts suggested that survival of patients treated with …

Objective To determine characteristics, outcomes, and clinical factors associated with death
in patients with COVID-19 requiring extracorporeal membrane oxygenation (ECMO) support …

Background: To report and compare the characteristics and outcomes of COVID-19 patients
on extracorporeal membrane oxygenation (ECMO) to non-COVID-19 acute respiratory …

Currently, little in-depth evidence is known about the application of extracorporeal
membrane oxygenation (ECMO) therapy in coronavirus disease 2019 (COVID-19) patients …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has placed extraordinary
strain on global healthcare systems. Use of extracorporeal membrane oxygenation (ECMO) …

Objectives The authors evaluated the outcome of adult patients with coronavirus disease
2019 (COVID-19)–related acute respiratory distress syndrome (ARDS) requiring the use of …

OBJECTIVES: To compare complications and mortality between patients that required
extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress …

Severe cases of coronavirus disease 2019 (COVID-19) cannot be adequately managed with
mechanical ventilation alone. The role and outcome of extracorporeal membrane …

Abstract As coronavirus disease 2019 (COVID-19) cases surge worldwide, an urgent need
exists to enhance our understanding of the role of extracorporeal membrane oxygenation …